Skip to content
SBRT Radiation Therapy - Stereotactic Body Radiation Therapy
Radiation Oncology

SBRT Radiation Therapy - Stereotactic Body Radiation Therapy

About This Department

 
Stereotactic Radiotherapy

Three sessions controlled 97.6 percent of early lung tumors at three years. SBRT compresses a course of radiotherapy into one to five visits.

The lung result comes from a North American trial in JAMA, in patients too unwell for surgery whose tumors, with older radiotherapy, were controlled in only three or four cases out of ten. Randomized trials have since tested the same approach in the prostate, in the spine and in cancers that have spread to a few sites. Each of those trials also recorded harm. This page reports both. Send us your pathology, your scans and your treatment history, and a radiation oncologist will tell you whether your tumor is one that SBRT suits.

97.6%
Early lung tumors controlled at three years
5 sessions
Prostate course, matching 20 or 39 in a phase 3 trial
35% vs 14%
Complete relief of spinal pain, SBRT against standard
Free
Review of your scans and history
Free consultation
SBRT in one sentence
Stereotactic body radiation therapy, also written SABR, destroys a small, well-defined tumor with one to five very large doses of radiation, each aimed to within a millimeter or two, in place of the 20 to 39 small daily doses of a conventional course.

What makes SBRT different from ordinary radiotherapy?

Conventional radiotherapy works by repetition. A dose of about 2 gray is given every weekday for weeks, healthy tissue repairs itself overnight a little better than tumor does, and the difference adds up. SBRT abandons that logic. A single session delivers 7 to 20 gray, enough to destroy whatever receives it (doctors call such a dose ablative), and the protection of healthy tissue comes entirely from geometry. Dose must be confined to the tumor with a margin of a few millimeters and must fall away steeply outside it. A conventional course forgives a few millimeters of error on a given day, because 30 other days average it out. Five sessions do not.

Four technical conditions follow from that, and a unit offering SBRT should be able to describe how it meets each.

  1. Rigid, reproducible positioning. A vacuum cushion molded to the body, or a mask for targets near the neck.
  2. Control of breathing motion. Lung, liver, pancreas and kidney tumors move by a centimeter or more with each breath. A four-dimensional planning CT records the motion, and treatment is either timed to one phase of breathing, given during a breath-hold, or planned to cover the measured path.
  3. Imaging before every session. A cone-beam CT on the treatment machine is matched to the plan and the couch corrected before the beam is switched on. For the prostate, some units implant tiny gold markers beforehand so that the gland itself can be seen.
  4. Physics checks on every plan. The plan is delivered to a measuring device and verified before the patient is treated.

What do the trials show?

Four terms used below
Local control means the treated tumor has not regrown. Gray is the unit of radiation dose. Fraction means one session. Side effects are graded from 1, mild, to 5, fatal, and grade 2 means symptoms that need treatment or limit daily activity.
Early lung cancer in patients who cannot have surgery
In the RTOG 0236 trial, 55 patients received 54 gray in three sessions over one and a half to two weeks. Three-year control of the treated tumor was 97.6 percent and three-year survival 55.8 percent, in a group whose other illnesses ruled out an operation. Grade 3 side effects occurred in 12.7 percent and grade 4 in 3.6 percent. Nobody died of the treatment. The randomized CHISEL trial in Australia and New Zealand then compared SBRT with standard radiotherapy in 101 patients, and the treated tumor progressed in 14 percent after SBRT against 31 percent after standard treatment.
Localized prostate cancer
PACE-B randomized 874 men with low or intermediate-risk disease at 38 centers to five sessions of SBRT over one to two weeks, or to conventional courses of 20 or 39 sessions. At five years, 95.8 percent of the SBRT group and 94.6 percent of the conventional group were free of relapse, which met the test for non-inferiority. The trial appeared in the New England Journal of Medicine in 2024.
Cancer that has spread to a few places
SABR-COMET, a phase 2 trial in The Lancet, enrolled 99 patients whose original tumor was controlled and who had one to five metastases. Adding SBRT to every visible deposit lengthened median survival from 28 months to 41.
Painful spinal metastases
A Canadian and Australian trial in The Lancet Oncology randomized 229 patients to SBRT, 24 gray in two sessions, or to conventional treatment, 20 gray in five. Three months later pain had gone completely in 35 percent after SBRT and 14 percent after conventional radiotherapy. There were no treatment deaths.
The other side of the ledger
In PACE-B, bladder and urinary side effects of grade 2 or worse over five years affected 26.9 percent of men after SBRT and 18.3 percent after conventional treatment. Bowel effects were the same in both groups, about 10 percent. In SABR-COMET, side effects of grade 2 or worse occurred in 29 percent of patients given SBRT against 9 percent of controls, and three of the 66 patients treated with SBRT, 4.5 percent, died of its complications. Large doses close to airways, bowel and major vessels can do serious damage, and selection of the right tumors is the main safety measure.
Liver, pancreas, kidney, adrenal gland and lymph nodes
SBRT is used for primary liver cancer and liver metastases when surgery or ablation is not possible, for selected pancreatic and kidney tumors, and for isolated deposits in the adrenal glands or lymph nodes. Results come mainly from single-arm studies, and proximity to the stomach and bowel often decides whether a safe plan exists. The reply to your file will say how strong the evidence is for your situation.
SBRT has earned its place in early lung cancer, in low and intermediate-risk prostate cancer and in painful spinal deposits. For limited metastatic disease the evidence is promising and still of phase 2 quality.

How is treatment planned for someone traveling to Istanbul?

For a patient from abroad the calendar counts for a great deal, since the whole of an SBRT treatment, from the first consultation to the last session, fits into a stay during which a conventional course of radiotherapy would barely have started.

Days to allow

Planning takes longer than treating. Allow for both.

This table scrolls sideways on a narrow screen. Swipe or drag to see every column.

Usual schedules, with planning time included
Site Sessions Pattern Total stay
Lung, peripheral 3 to 5 Every second day About three weeks
Lung, close to the central airways 8 Daily or alternate days, at a gentler dose per session Three to four weeks
Prostate 5 Alternate days over one to two weeks Three weeks, longer if gold markers are placed first
Spine and bone 1 to 5 Daily Two weeks
Liver, pancreas, kidney, adrenal, lymph node 3 to 5 Alternate days About three weeks
Several metastases 3 to 8 per site Sites are treated in sequence or together Three to four weeks
Remote review
A radiation oncologist reads the pathology, the PET-CT or MRI and your treatment history, and states whether SBRT is suitable, for which lesions, and in how many sessions.
Consultation and tumor board
In person, with an interpreter. Surgery, ablation and drug treatment are weighed against SBRT with the surgeons and medical oncologists of the same hospital.
Simulation
The cushion or mask is made, and a planning CT is taken in the treatment position, in four dimensions for anything that moves with breathing. MRI or PET images are fused in.
Planning and checks
Five to seven working days for contouring, planning and physics verification. You are free during this time.
Treatment and discharge
The sessions, a review with the oncologist, and a treatment summary that lists the dose to the target and to every nearby organ.
SBRT sets no waiting period before flying. You can leave the day after the last session, and you are not radioactive at any point.
  • For the remote review, send the pathology report and any molecular results.
  • PET-CT, CT and MRI reports with the images, taken within the past six to eight weeks.
  • Lung function tests for a lung tumor, PSA history and prostate MRI for the prostate, liver blood tests for the liver.
  • A summary of every earlier treatment, above all any radiotherapy, with its doses.
  • Your medication list, a note of any pacemaker, and how far you can walk without stopping.

In the room
You lie in your cushion, the lasers are aligned to your marks, and the radiographers leave. They see and hear you throughout.
Imaging and correction
A cone-beam CT is taken and matched to the plan. The couch moves by millimeters. For a breath-hold treatment you are coached through a screen or by voice.
Delivery
Arcs of radiation for 5 to 15 minutes of beam time. Plan on 30 to 45 minutes in the room, longer than a conventional session, because nothing starts until the position is right.

Afterward

  1. The same evening. Tiredness, sometimes mild nausea after abdominal treatment. After spinal SBRT, a flare of pain for a day or two that steroids prevent or settle.
  2. The first month. Tiredness lifts. After prostate SBRT, urinary frequency and urgency peak in the second week and ease over a month or two.
  3. Three months. The first scan, done at home. After lung SBRT the treated area scars, and the scar can look alarming on CT to a radiologist who does not know SBRT was given. Send the treatment summary with every scan request.
  4. Six months and beyond. Scans at intervals set by your own oncologist, who should also watch for the late effects that, where they occur, appear in this period.

What are the risks, and does the machine matter?

Side effects of SBRT depend on what lies next to the tumor. During treatment there is little to notice. What counts arrives weeks or months later, in the organ that sat closest to the high dose, and the rows below give the pattern for each of the common sites along with the patients in whom the risk runs higher than average.

Lung
Inflammation of the treated lung one to six months afterward, with cough and breathlessness, treated with steroids. Chest wall pain or a rib fracture months later when the tumor lay against the ribs. Tumors close to the main airways carry a risk of serious bleeding or airway damage at high doses per session, so they are given more sessions at a lower dose, or another treatment.
Prostate
Urinary frequency, urgency and a weak stream in the first weeks, lasting effects of grade 2 or worse in about a quarter of men over five years in PACE-B, and bowel effects in about a tenth. Men with severe urinary symptoms or a very large gland beforehand do worse and may be advised to have a conventional course.
Spine
A pain flare in the first days. A compression fracture of the treated vertebra in the following months, more likely when the bone was already weakened. Damage to the spinal cord is very rare and is what the dose limits in planning exist to prevent.
Liver and upper abdomen
Nausea and tiredness. Ulceration or bleeding of the stomach or bowel when these lie against the target. Worsening of liver function in patients whose liver was already poor, which is why liver blood tests decide eligibility.
Is CyberKnife better than SBRT on a linear accelerator?
No trial has shown a difference in outcome. CyberKnife is a small accelerator on a robotic arm, and a modern linear accelerator delivers SBRT with rotating arcs and on-board CT imaging. PACE-B treated men on both kinds of machine. Linear accelerators dominate in Turkey as well. In a 2021 survey by the Turkish Society for Radiation Oncology, published in the Turkish Journal of Oncology, 92 percent of respondents delivered stereotactic treatment on them. Biruni Hospital treats on an Elekta Versa HD linear accelerator. It has a 160-leaf collimator, a high-dose-rate mode that shortens long SBRT sessions, and cone-beam CT. The hospital does not have a CyberKnife or a Gamma Knife, and if your case calls for one, the reply to your file will say so.
Is SBRT an alternative to surgery for early lung cancer?
For patients fit for an operation, surgery remains the standard, because it also removes and examines the lymph nodes. SBRT is the treatment of choice for patients who cannot have surgery, in the words of the CHISEL investigators, and a reasonable option for those who decline it after a full discussion.
Can SBRT be given to an area treated before?
Sometimes. It depends on the dose the nearby organs have already received, which is why the records of earlier radiotherapy matter so much.

What decides the cost?

Hospitals quote SBRT per treated site, and the session count changes the figure less than patients expect, because most of the work lies in planning. Lesions multiply it. Each additional one needs its own contours, plan and checks, and motion management adds a four-dimensional scan and longer sessions. PET-CT or MRI repeated for planning, gold markers and their placement under ultrasound, and a rectal spacer for prostate patients are separate items where they are used, and any drug treatment given alongside belongs to medical oncology and is quoted by that department. Hotel costs come to a fraction of what a conventional course demands, and for many families that saving, three weeks of accommodation in place of eight or nine, decides the matter. Your own history moves the quote too. Earlier radiotherapy nearby, a pacemaker, poor lung function or liver disease all add assessments before anyone will sign off a plan.

Packages published in Turkey for stereotactic treatment cover three to five sessions with consultation, planning images, the sessions themselves, a follow-up consultation and transfers, and they describe a stay of eight to ten days in the country. Treat that stay as a minimum. Compare quotes on the number of lesions covered, whether imaging before every session is included, and whether the treatment summary with organ doses is issued in English.

Your own figure follows the free review of your file.

What about language, companions and follow-up at home?

One coordinator from the international patients team is assigned from your first message and stays on your case. The team works in English, Arabic, French, Russian, Serbian, Romanian and Spanish and arranges interpreting in other languages on request, and an interpreter attends the consultation and consent. An invitation letter naming the hospital and the treating doctor is sent about ten days before travel, and the international patients office arranges the airport transfer, the hotel for you and a companion, and the rides to each session. SBRT needs no admission. Should you be admitted for any other reason, the room has a companion bed. Halal, vegetarian and diabetic meals are available. A prayer room is on site. A request for a female doctor is passed to the department and met wherever the rota allows. Surgery, chemotherapy and radiotherapy share one site, so a change of plan at the tumor board does not mean a change of hospital.

Back home, the coordinator stays reachable on the same WhatsApp number. Send your scans there for the treating oncologist to see.

See a doctor locally the same day for coughing up blood, new breathlessness or fever after lung treatment, for inability to pass urine after prostate treatment, for new leg weakness or loss of bladder control after spinal treatment, and for black stools or vomiting blood after abdominal treatment.

SBRT FAQ

What is the difference between SBRT and conventional radiotherapy?
SBRT gives one to five very large doses aimed with millimeter accuracy, and conventional radiotherapy gives 20 to 39 small daily doses. SBRT suits small, well-defined tumors away from sensitive hollow organs.
What is the success rate of SBRT for early lung cancer?
In the RTOG 0236 trial, 97.6 percent of treated tumors were controlled at three years, and three-year survival was 55.8 percent in patients who were too unwell for surgery.
Is five-session SBRT as good as a long course for prostate cancer?
For low and intermediate-risk disease, yes. In the PACE-B trial of 874 men, 95.8 percent were free of relapse at five years after SBRT and 94.6 percent after conventional radiotherapy. Lasting urinary side effects were more frequent after SBRT, 26.9 against 18.3 percent.
How long will I need to stay in Istanbul?
Two to three weeks for most treatments, covering consultation, simulation, five to seven working days of planning and the sessions. You can fly the day after the last one.
Does SBRT hurt?
No. You feel nothing during the session. The demanding part is lying still for up to 45 minutes.
Can my family come with me?
Yes. The international patients office arranges a hotel for you and a companion and the transport to each session.

References

  1. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070-1076.
  2. Ball D, Mai GT, Vinod S, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncology. 2019;20(4):494-503.
  3. van As N, Griffin C, Tree A, et al. Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. New England Journal of Medicine. 2024;391(15):1413-1425.
  4. Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051-2058.
  5. Sahgal A, Myrehaug SD, Siva S, et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. Lancet Oncology. 2021;22(7):1023-1033.

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Özcan YILDIZ, Medical Oncology.

Related Treatments

View All